StockDuty ← Dashboard Oct 19, 2026 10:46 AM ET
SignalMacro

Belite Bio to uplist to Nasdaq Global Select Market

Belite Bio uplisting to Nasdaq Global Select Market signals increased market visibility.

What happened: Belite Bio (BLTE) received Nasdaq approval to transfer its listing from the Nasdaq Capital Market to the Nasdaq Global Select Market. Key numbers: Trading on the Nasdaq Global Select Market begins at market open on October 19, 2026. Why it matters: The content does not state any consequence or significance beyond the listing transfer itself.
Belite Bio (BLTE) received Nasdaq approval to transfer its listing from the Nasdaq Capital Market to the Nasdaq Global Select Market.
The content does not state any consequence or significance beyond the listing transfer itself.
Sources